In both cohorts analyzed with qRT-PCR a significant overexpression of SMPDL3B could be seen in tumor samples compared to BPH samples (Tissue scan: 6.46× and Mannheim: 37.81×, Mann–Whitney for both p < 0.001). Here, SMPDL3B is linked to benign prostatic hyperplasia.